Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Asher

Showing results (691-700 of 6,834) with videos related to

Pageof 684
Sort By:
Nature Reviews. Drug Discovery|May 4, 2016
EMA greenlights second gene therapyAsher Mullard
Nature Reviews. Drug Discovery|May 4, 2016
FDA rejects first cognitive claim for antidepressantAsher Mullard
Nature Reviews. Drug Discovery|July 1, 2016
EMA provides first glimpse of PRIME candidatesAsher Mullard
The Lancet. Respiratory Medicine|January 6, 2018
The Sparrow by Asher SvidenskyAsher Svidensky
Nature Reviews. Drug Discovery|September 5, 2020
FDA approves first GPCR biased agonistAsher Mullard
Nature Reviews. Drug Discovery|September 5, 2020
FDA approves first BCMA-targeted therapeuticAsher Mullard
Nature Biotechnology|November 4, 2020
IRAK4 degrader to take on innate immunityAsher Mullard
Nature Reviews. Drug Discovery|November 11, 2020
Addressing cancer's grand challengesAsher Mullard
Nature Reviews. Drug Discovery|January 10, 2023
FDA approves first-in-class HIV capsid inhibitorAsher Mullard
Nature Reviews. Drug Discovery|June 2, 2021
Amgen overcomes historically undruggable target, with FDA nod for first KRAS inhibitorAsher Mullard
Pageof 684

Showing results (691-700 of 6,834) with videos related to

Sort By:
Pageof 684
Nature Reviews. Drug Discovery|May 4, 2016
EMA greenlights second gene therapyAsher Mullard
Nature Reviews. Drug Discovery|May 4, 2016
FDA rejects first cognitive claim for antidepressantAsher Mullard
Nature Reviews. Drug Discovery|July 1, 2016
EMA provides first glimpse of PRIME candidatesAsher Mullard
The Lancet. Respiratory Medicine|January 6, 2018
The Sparrow by Asher SvidenskyAsher Svidensky
Nature Reviews. Drug Discovery|September 5, 2020
FDA approves first GPCR biased agonistAsher Mullard
Nature Reviews. Drug Discovery|September 5, 2020
FDA approves first BCMA-targeted therapeuticAsher Mullard
Nature Biotechnology|November 4, 2020
IRAK4 degrader to take on innate immunityAsher Mullard
Nature Reviews. Drug Discovery|November 11, 2020
Addressing cancer's grand challengesAsher Mullard
Nature Reviews. Drug Discovery|January 10, 2023
FDA approves first-in-class HIV capsid inhibitorAsher Mullard
Nature Reviews. Drug Discovery|June 2, 2021
Amgen overcomes historically undruggable target, with FDA nod for first KRAS inhibitorAsher Mullard
Pageof 684